Raymond Wagenknecht | San Diego Intellectual Property Lawyer

Raymond is a patent attorney with strong ties to San Diego’s research and development community and has nearly 15 years of experience protecting and enforcing intellectual property rights. Raymond’s practice includes comprehensive patent and trademark representation, including patent and trademark prosecution, due diligence, freedom to operate (FTO) analysis, and trademark opposition proceedings.

Prior to becoming a patent attorney, Raymond was actively involved in immunology research within the Department of Medicine at the University of California, San Diego (UCSD). Afterwards, he joined one of San Diego’s early Hybritech spin-off companies to help develop a proprietary 2D gel electrophoresis method of analyzing serum proteins. Raymond’s scientific career is peer reviewed by co-authorship on a number of scientific papers in the area of immunology and drug discovery.

Position	Organization	Location	Duration
Patent Attorney	Wagenknecht IP Law Group PC	San Diego, CA	Present

School	Degree	Major	Graduation
University of San Diego School of Law	J.D.	Law School	2002
University of California San Diego | La Jolla	Bachelors	Molecular Biology	1995

State / Court	Date
California	2003

• Federal Circuit Bar Association | Member | 2012 - Present
  San Diego Intellectual Property Law Association | Member | 2005 - Present
  San Diego County Bar Association | Member | 2003 - Present
  American Bar Association | Member | 2003 - Present
  United States Patent and Trademark Office | Member | 2002 - Present
  Corporate Directors Forum | Member
  Device Alliance | Orange County | Member
  San Diego Venture Group | Member
  San Diego Entrepreneurs Exchange | Member
  She Founder's | University of San Diego's SBDC | Sponsor

• Practioner of the Year Intellectual Property USA | Aquisition International | 2016
  Top Patent Firms | IP Today Magazine | 2011-2014
  Who’s Who in Tech & Biotech | San Diego Daily Transcript | 2013
  Obtained well over 100 US Patents

• A B Cell Superantigen-induced Persistent ‘Hole’ in the B-1 Repertoire J. Silverman, S. Cary, D. Dwyer, L. Luo, R. Wagenknechtand V.E. Curtiss. J. Exp. Med., 2000 Jul 3;192(1):87-98.
  
  Characterization of Superantigen-Induced Clonal Deletion with a Novel Clan III-Restricted Avian Monoclonal Antibody: Exploiting Evolutionary Distance to Create Antibodies Specific for a Conserved VH Region Surface Cary SP, Lee J, Wagenknecht R, Silverman GJ Immunol., 2000 May 1;164(9):4730-41
  
  A B-Cell Superantigen That Targets B-1 Lymphocytes” Silverman GJ, Cary S, Graille M, Curtiss VE, Wagenknecht R, Luo L, Dwyer D, Goodyear C, Corper AL, Stura EA, Charbonnier JB Curr Top Microbiol Immunol. 2000; 252:251-63
  
  Improved two-dimensional gel electrophoresis representation of serum proteins using ProtoClearTM Lollo BA, Harvey S, Liao J, Stevens AC, Wagenknecht R, Sayen R, Whaley J, Sajjadi FG. Electrophoresis, 1999 Apr-May;20:854-9
  
  In Vivo Consequences of a B-Cell Superantigen Immunization” Gregg J. Silverman, Jayakar Nayak, Raymond Wagenknecht, Klaus Warnatz. N.Y. Acad. Sci., 1997 Apr 5;815:105-110

Sun.	Mon.	Tue.	Wed.	Thu.	Fri.	Sat.
	8:00 am - 6:00 pm	8:00 am - 6:00 pm	8:00 am - 6:00 pm	8:00 am - 6:00 pm	8:00 am - 6:00 pm

• YouTube
• Raymond Wagenknecht
• LinkedIn | Raymond Wagenknecht
• LinkedIn | Wagenknecht IP Law Group
• Facebook
• Avvo | Raymond Wagenknecht